A. van Bochove

发表

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature

C. Punt, M. Koopman, S. Teerenstra, 2011, Annals of Surgical Oncology.

Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer.

R. C. Coombes, J. Stebbing, J. Bliss, 2016, European journal of cancer.

Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.

J. Nortier, G. Hospers, N. Mulder, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.

A. Stiggelbout, H. Gelderblom, E. van Werkhoven, 2015, Journal of geriatric oncology.

A phase I dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer.

J. Nortier, P. Slee, C. Rodenburg, 2004, The Netherlands journal of medicine.

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

J. V. van Meerbeeck, S. Senan, P. Baas, 2006, British Journal of Cancer.

Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.

W. M. Smit, P. Willemse, A. Westermann, 2011, European journal of cancer.

Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.

G. Peters, G. Giaccone, J. Kroep, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study.

P. Neven, H. Guchelaar, S. Böhringer, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

P. Cuijpers, A. Beekman, M. V. D. van der Linden, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.

C. V. van Groeningen, L. W. Wormhoudt, G. Giaccone, 2005, European journal of cancer.

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.

E. Smit, H. van Tinteren, H. Groen, 2007, European journal of cancer.

The pharmacokinetic plasma profile of mitomycin C, measured after sequential intermittent intravenous administration.

J. Lankelma, J. Verweij, H. Pinedo, 1988, European Journal of Cancer and Clinical Oncology.

Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.

G. Peters, G. Giaccone, J. Kroep, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

High Risk Stage 2 and Stage 3 Colon Cancer, Predictors of Recurrence and Effect of Adjuvant Therapy in a Nonselected Population

R. Loffeld, A. van Bochove, S. Bakker, 2015, International scholarly research notices.

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

G. Giaccone, E. Smit, M. Krzakowski, 2003, European Journal of Cancer.

Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial.

W. V. van Harten, N. Aaronson, J. Kieffer, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol

M. Pepels, L. van Zuylen, C. Pitz, 2020, BMC Palliative Care.

Impact of age and comorbidity on survival in colorectal cancer.

R. Loffeld, A. van Bochove, S. Bakker, 2015, Journal of gastrointestinal oncology.

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04).

S. Linn, M. Kok, J. Wesseling, 2018, European journal of cancer.

Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy

M. Schmidt, S. Linn, M. Kok, 2017, Oncotarget.

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

H. Putter, H. Pijl, V. Smit, 2015, Breast Cancer Research and Treatment.

Early intervention with epoetin-alfa during platinum-based chemotherapy.

H. Pinedo, G Giaccone, J Savonije, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01).

H. Putter, J. Nortier, V. Smit, 2016, Breast.

The localisation of cancer in the sigmoid, rectum or rectosigmoid junction using endoscopy or radiology-What is the most accurate method?

M. Flens, R. Loffeld, F. D. den Boer, 2014, Journal of gastrointestinal oncology.

W. V. van Harten, N. Aaronson, J. Kieffer, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

F. van Coevorden, K. Sikorska, J. V. van Sandick, 2018, The Lancet. Oncology.